Flecainide Acetate
32 NDCs across 9 manufacturers|32 Generic,0 Brand
Flecainide Acetate is used to treat atrial fibrillation, supraventricular tachycardia and ventricular tachycardia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 31, 1985, and the first generic was approved Jul 31, 2001. FDA's Orange Book lists 24 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $53 million on Flecainide Acetate across 1.3 million claims for 330,000 beneficiaries.
Flecainide Acetate is available as 32 NDCs from 9 manufacturers (32 generic, 0 brand), with NADAC prices from $0.10 to $0.50 per EA — the most expensive product costs about 5.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
32
32G / 0B
Manufacturers
9
competing in market
Price Spread
$0.10 – $0.50
per EA
7d Activity
avg -0.5% WoW · of 32 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Hikma Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antiarrhythmic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing FLECAINIDE ACETATE(3 pricing outliers)
Frequently Asked Questions
What is Flecainide Acetate used to treat?
Flecainide Acetate is used to treat atrial fibrillation, supraventricular tachycardia and ventricular tachycardia, per the National Library of Medicine's MED-RT classification.
When did Flecainide Acetate become available as a generic?
FDA approved the first generic Flecainide Acetate (ANDA) on Jul 31, 2001. The Orange Book currently lists 24 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Flecainide Acetate?
In 2024, Medicare Part D spent $53 million on Flecainide Acetate across 1.3 million claims for 330,000 beneficiaries.
How many Flecainide Acetate products are on the market?
The Flecainide Acetate drug market contains 32 NDCs from 9 manufacturers — 32 generic and 0 brand products.
What is the price range for Flecainide Acetate?
NADAC reference prices for Flecainide Acetate range from $0.0972 to $0.4993 per EA — the most expensive product costs about 5.1× the cheapest.
Which manufacturers make Flecainide Acetate?
9 manufacturers list Flecainide Acetate in NADAC. Ranked by number of NDCs, the largest are Hikma Pharmaceuticals USA Inc. (9), Chartwell RX LLC (3), Aurobindo Pharma Limited (3), Unichem Pharmaceuticals (USA) Inc. (3), Epic Pharma LLC (3).
How has the price of Flecainide Acetate changed recently?
Over the past 7 days, 8 Flecainide Acetate NDCs rose and 20 fell, with a market-wide average change of -0.5%.